InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Shuttle Pharmaceuticals Holdings, Inc.

SHPH Clue Score34
United States Fiscal year ends December CIK 0001757499
$5.33 -3.96% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.33 +835.09% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Aug 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2021Operating income−1.7Net income−1.2Fiscal year 2022Operating income−2.3Net income−5.0EPS, diluted−5.04Fiscal year 2023Operating income−5.9Net income−6.6EPS, diluted−3.53Fiscal year 2024Operating income−7.7Net income−9.1EPS, diluted−82.60Fiscal year 2025Operating income−11.9Net income−11.7EPS, diluted−7.16
FY2021FY2022FY2023FY2024FY2025
Operating income −1.7 −2.3 −5.9 −7.7 −11.9
Net income −1.2 −5.0 −6.6 −9.1 −11.7
Growth
EPS, diluted n/a −5.04 −3.53 −82.60 −7.16

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−0.3Fiscal year 2022Operating cash flow−2.7Fiscal year 2023Operating cash flow−5.6Capital expenditure−0.0Free cash flow−5.6Fiscal year 2024Operating cash flow−7.3Fiscal year 2025Operating cash flow−9.5
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.3 −2.7 −5.6 −7.3 −9.5
Capital expenditure n/a n/a −0.0 n/a n/a
Free cash flow n/a n/a −5.6 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash0.5Total debt0.1Net cash (debt)0.4Shareholders’ equity−1.8Fiscal year 2022Cash8.4Shareholders’ equity7.7Fiscal year 2023Cash2.6Shareholders’ equity4.1Fiscal year 2024Cash1.9Shareholders’ equity0.7Fiscal year 2025Cash0.3Shareholders’ equity2.3
FY2021FY2022FY2023FY2024FY2025
Cash 0.5 8.4 2.6 1.9 0.3
Total debt 0.1 n/a n/a n/a n/a
Net cash (debt) 0.4 n/a n/a n/a n/a
Shareholders’ equity −1.8 7.7 4.1 0.7 2.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −65.1% −162.6% −1,289.5% −519.9%
−176.8% −57.7% −110.8% −364.9% −111.9%
Balance and payout
349.9% 11.3% 31.9% 71.7% 78.5%